{
    "code": "02005493",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02005493",
    "time": "2020-02-25 08:38:12",
    "許可證字號": "衛署藥輸字第005493號",
    "註銷狀態": "已註銷",
    "註銷日期": "79\/12\/05",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "74\/01\/16",
    "發證日期": "67\/01\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200549302",
    "中文品名": "赫巴林注射液",
    "英文品名": "HEPARIN SODIUM INJECTION",
    "適應症": "靜脈栓塞、肺插塞、心肌梗塞形成、僧帽瓣狹窄、預防靜脈栓塞",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "HEPARIN SODIUM",
    "限制項目": "02輸　入",
    "申請商名稱": "0605801100  光生行股份有限公司",
    "申請商地址": "台北巿羅斯福路一段１１９巷１６號",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0373000  MITSUBISHI-TOKYO PHARMACEUTICALS,INC.(ASHIKAGA PLANT)",
            "製造廠廠址": "588-3,KUBOTA-CHO,ASHIKAGA-CITY,TOCHIGI-PREFECTURE,JAPAN2-6, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO JAPAN",
            "製造廠公司地址": "2-6, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012400520",
            "成分名稱": "HEPARIN SODIUM",
            "含量描述": "5000",
            "含量": "5000.0000000000",
            "單位": "U (UN"
        }
    ]
}